Weight gain related to treatment with atypical antipsychotics is due to activation of PKC-β
{{output}}
Atypical antipsychotics (APDs) are currently used in clinical practice for a variety of mental disorders such as schizophrenia, bipolar disorder and severe behavioral disturbances. A well-known disadvantage of using these compounds is a propensity for weight g... ...
